• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Prevalence of Mycobacterium tuberculosis Infection Among Cancer Patients Receiving Chemotherapy in a Tertiary Care Center.某三级医疗中心接受化疗的癌症患者中结核分枝杆菌感染的患病率
Cureus. 2022 Nov 30;14(11):e32068. doi: 10.7759/cureus.32068. eCollection 2022 Nov.
2
[Evolution of IGRA researches].[IGRA研究的进展]
Kekkaku. 2008 Sep;83(9):641-52.
3
Prevalence of Latent Tuberculosis Infection Among Rheumatology Patients and Management Practices in the United Arab Emirates: A Single-Center Retrospective Cohort Study.阿联酋风湿病患者中潜伏性结核感染的患病率及管理实践:一项单中心回顾性队列研究
Cureus. 2023 Dec 15;15(12):e50581. doi: 10.7759/cureus.50581. eCollection 2023 Dec.
4
Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.美国移民接受γ-干扰素释放试验筛查后的结核病进展率
BMC Public Health. 2016 Aug 25;16(1):875. doi: 10.1186/s12889-016-3519-6.
5
Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.一种肝素结合血凝素干扰素-γ释放试验对检测HIV感染患者结核分枝杆菌感染的贡献:与结核菌素皮肤试验和全血γ-干扰素释放试验(QFT-GIT)的比较
BMC Infect Dis. 2015 Feb 14;15:59. doi: 10.1186/s12879-015-0796-0.
6
Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.TST 与 QFT-TBGold Plus 用于五岁以下儿童潜伏性结核病筛查的不一致性:一项中期分析。
J Trop Pediatr. 2021 Dec 8;67(6). doi: 10.1093/tropej/fmab103.
7
Decreased annual risk of tuberculosis infection in South Korean healthcare workers using interferon-gamma release assay between 1986 and 2005.1986 年至 2005 年期间,韩国医护人员使用干扰素-γ释放试验,结核感染年发病率降低。
BMC Infect Dis. 2021 Nov 16;21(1):1161. doi: 10.1186/s12879-021-06855-5.
8
Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.两种干扰素-γ释放检测方法(QuantiFERON-TB Gold In-Tube和T-SPOT.TB)在HIV感染成人潜伏性结核感染检测中的比较。
Int J STD AIDS. 2013 Oct;24(10):775-9. doi: 10.1177/0956462413486459. Epub 2013 Jul 15.
9
Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.在坦桑尼亚姆万扎,采用 QuantiFERON-TB Gold assay 和 ESAT-6 free IGRA 检测青少年结核分枝杆菌感染的流行率。
PLoS One. 2021 Jun 7;16(6):e0252808. doi: 10.1371/journal.pone.0252808. eCollection 2021.
10
The risk of tuberculosis infection in 410 Saudipatients receiving adalimumab therapy.410 例接受阿达木单抗治疗的沙特患者的结核感染风险。
Ann Saudi Med. 2021 Sep-Oct;41(5):285-292. doi: 10.5144/0256-4947.2021.285. Epub 2021 Oct 7.

引用本文的文献

1
Burden of tuberculosis among patients with cancer: a comprehensive systematic review and meta-analysis of global data.癌症患者中的结核病负担:对全球数据的全面系统评价和荟萃分析
JNCI Cancer Spectr. 2025 Jul 1;9(4). doi: 10.1093/jncics/pkaf062.
2
Coexisting Lung Cancer and Pulmonary Tuberculosis: A Comprehensive Review From Incidence to Management.肺癌与肺结核并存:从发病率到治疗的全面综述
Cancer Rep (Hoboken). 2025 May;8(5):e70213. doi: 10.1002/cnr2.70213.
3
Investigation of the prevalence of latent tuberculosis in cancer patients compared to non-cancer patients: a case-control study.癌症患者与非癌症患者潜伏性结核病患病率的调查:一项病例对照研究。
Oncol Rev. 2024 Dec 4;18:1445678. doi: 10.3389/or.2024.1445678. eCollection 2024.
4
Open questions between immune checkpoint inhibitors and tuberculosis incidence.免疫检查点抑制剂与结核病发病率之间的未决问题。
J Thorac Dis. 2024 Aug 31;16(8):5484-5486. doi: 10.21037/jtd-24-890. Epub 2024 Aug 5.
5
The controversy of immune checkpoint inhibition and risk of mycobacterial infections: the need for further studies and continued discussions on this puzzling issue.免疫检查点抑制与分枝杆菌感染风险的争议:对这一棘手问题进行进一步研究并持续讨论的必要性。
J Thorac Dis. 2024 Aug 31;16(8):5487-5489. doi: 10.21037/jtd-24-1005. Epub 2024 Aug 28.
6
The Prevalence of Mycobacterium Tuberculosis Infection in Saudi Arabia: A Systematic Review and Meta-analysis.沙特阿拉伯的结核分枝杆菌感染流行率:系统评价和荟萃分析。
J Epidemiol Glob Health. 2024 Sep;14(3):658-676. doi: 10.1007/s44197-024-00274-w. Epub 2024 Jul 24.
7
Advancements in Artificial Intelligence for the Diagnosis of Multidrug Resistance and Extensively Drug-Resistant Tuberculosis: A Comprehensive Review.人工智能在耐多药和广泛耐药结核病诊断中的进展:综述
Cureus. 2024 May 14;16(5):e60280. doi: 10.7759/cureus.60280. eCollection 2024 May.
8
Disseminated tuberculosis after Polatuzumab-Vedotin based chemoimmunotherapy in a patient with Burkitt's lymphoma.一名伯基特淋巴瘤患者在接受基于泊洛妥珠单抗-维达莎的化疗免疫治疗后发生播散性结核病。
Clin Case Rep. 2024 May 7;12(5):e8838. doi: 10.1002/ccr3.8838. eCollection 2024 May.

本文引用的文献

1
Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study.免疫检查点抑制剂治疗的癌症患者的结核病风险:一项全国性观察研究。
J Immunother Cancer. 2021 Sep;9(9). doi: 10.1136/jitc-2021-002960.
2
Incidence of and Risk Factors for Tuberculosis among Cancer Patients in Endemic Area: A Regional Cohort Study.高发地区癌症患者结核病的发病率和危险因素:一项区域性队列研究。
Asian Pac J Cancer Prev. 2020 Sep 1;21(9):2715-2721. doi: 10.31557/APJCP.2020.21.9.2715.
3
Forecasting the impact of population ageing on tuberculosis incidence.预测人口老龄化对结核病发病率的影响。
PLoS One. 2019 Sep 24;14(9):e0222937. doi: 10.1371/journal.pone.0222937. eCollection 2019.
4
Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations.免疫检查点抑制剂治疗后癌症患者结核病的再激活:当前证据和临床实践建议。
J Immunother Cancer. 2019 Sep 4;7(1):239. doi: 10.1186/s40425-019-0717-7.
5
The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse.恶性肿瘤患者结核负担:发病率、死亡率和复发率。
Sci Rep. 2019 Aug 15;9(1):11901. doi: 10.1038/s41598-019-48395-8.
6
The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study.癌症患者的结核病风险在淋巴瘤和骨髓增生异常综合征/骨髓增殖性肿瘤中最高:一项大型基于人群的队列研究。
Leuk Lymphoma. 2019 Mar;60(3):720-725. doi: 10.1080/10428194.2018.1499904. Epub 2018 Sep 6.
7
Risk of tuberculosis in patients with solid cancers and haematological malignancies: a systematic review and meta-analysis.实体瘤和血液恶性肿瘤患者的结核病风险:系统评价和荟萃分析。
Eur Respir J. 2017 Aug 24;50(2). doi: 10.1183/13993003.00157-2017. Print 2017 Aug.
8
Prevalence of Latent Mycobacterium Tuberculosis Infection (LTBI) in Saudi Arabia; Population based survey.沙特阿拉伯潜伏性结核分枝杆菌感染(LTBI)的患病率;基于人群的调查。
Int J Infect Dis. 2017 Jul;60:11-16. doi: 10.1016/j.ijid.2017.03.024. Epub 2017 Apr 6.
9
Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis.癌症患者活动性肺结核的风险:一项系统评价和荟萃分析。
Clin Infect Dis. 2017 Mar 1;64(5):635-644. doi: 10.1093/cid/ciw838. Epub 2016 Dec 16.
10
Reactivation of pulmonary tuberculosis during cancer treatment.癌症治疗期间肺结核的复发
Int J Mycobacteriol. 2015 Dec;4(4):337-40. doi: 10.1016/j.ijmyco.2015.05.015. Epub 2015 Jul 18.

某三级医疗中心接受化疗的癌症患者中结核分枝杆菌感染的患病率

The Prevalence of Mycobacterium tuberculosis Infection Among Cancer Patients Receiving Chemotherapy in a Tertiary Care Center.

作者信息

Aldabbagh Mona A, Abughasham Asma, Alansari Ghaday, Bougis Suaad, Melibari Ealaf, Alhatmi Nada, Khan Muhammad A, Jastaniah Wasil

机构信息

Department of Pediatrics, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Jeddah, SAU.

Medicine, King Saud Bin Abdulaziz University for Health Sciences College of Medicine, Jeddah, SAU.

出版信息

Cureus. 2022 Nov 30;14(11):e32068. doi: 10.7759/cureus.32068. eCollection 2022 Nov.

DOI:10.7759/cureus.32068
PMID:36600835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9803363/
Abstract

OBJECTIVE

To estimate the prevalence of tuberculosis (TB) infection among patients receiving cancer chemotherapy and to identify risk factors for latent TB reactivation.

METHODS

A cross-sectional study was conducted at a tertiary care center in Jeddah, Saudi Arabia. Patients were surveyed for TB risk factors, their records were reviewed for previous TB infection or disease, and blood samples were collected for interferon-gamma release assays (IGRAs).

RESULTS

A total of 203 patients were included. One hundred and twenty-five were females (62%). Median age was 52 years, and mean age was significantly higher in positive IGRA patients compared to negative IGRA (57.32 vs. 47.27; = 0.009). Twenty-five patients (12.3%) had evidence of TB infection, 16 (68%) among them had a latent TB infection, while the rest received treatment for an active TB disease. The rate of active disease among cancer patients was 8 (3.9%). Additionally, 92% (23) of those with positive IGRA had solid cancers ( = 0.007), and all active TB cases occurred in this group of solid cancers.

CONCLUSION

TB prevalence was higher in chemotherapy patients compared to the general Saudi population. Patients with solid tumors and older age had a greater risk of developing the infection, signifying the importance of preventing TB and malignancy coexistence by initiating screening policies in cancer patients.

摘要

目的

评估接受癌症化疗患者的结核病(TB)感染率,并确定潜伏性结核再激活的危险因素。

方法

在沙特阿拉伯吉达的一家三级医疗中心进行了一项横断面研究。对患者进行结核病危险因素调查,查阅其既往结核感染或疾病记录,并采集血样进行干扰素-γ释放试验(IGRAs)。

结果

共纳入203例患者。其中125例为女性(62%)。年龄中位数为52岁,IGRA阳性患者的平均年龄显著高于IGRA阴性患者(57.32岁对47.27岁;P = 0.009)。25例患者(12.3%)有结核感染证据,其中16例(68%)为潜伏性结核感染,其余接受活动性结核病治疗。癌症患者中的活动性疾病发生率为8例(3.9%)。此外,IGRA阳性者中有92%(23例)患有实体癌(P = 0.007),所有活动性结核病例均发生在这组实体癌患者中。

结论

与沙特普通人群相比,化疗患者中的结核病患病率更高。实体瘤患者和老年患者发生感染的风险更大,这表明通过在癌症患者中启动筛查政策来预防结核病和恶性肿瘤共存具有重要意义。